Exposure to Endocrine-Disrupting Chemicals Associated with Early Puberty in Girls

December 07, 2018 8:32 AM | Anonymous
December 7, 2018, MedPage Today  

Obesity may diminish survival in women with CLL who undergo chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR), a study from Germany found. 

Read more.

Powered by Wild Apricot Membership Software